Inotersen Subcutaneous and Orphenadrine Extended-Release Tablets
Determining the interaction of Inotersen Subcutaneous and Orphenadrine Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotersen
Brand name: Tegsedi
Synonyms: Inotersen
Generic Name: orphenadrine
Brand name: Norflex, Banflex, Orphenate, Flexoject, Flexon, Mio-Rel, Myolin, Orfro, Norflex Injectable, Antiflex
Synonyms: Orphenadrine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotersen Subcutaneous-Orphenadrine Injection
- Inotersen Subcutaneous-Orphenadrine w/A.C.
- Inotersen Subcutaneous-Orphenadrine, aspirin, and caffeine
- Inotersen Subcutaneous-Orphenate
- Inotersen Subcutaneous-Orphengesic
- Inotersen Subcutaneous-Orphengesic Forte
- Orphenadrine Extended-Release Tablets-Inotuzumab ozogamicin
- Orphenadrine Extended-Release Tablets-Inotuzumab ozogamicin Intravenous
- Orphenadrine Extended-Release Tablets-Inova
- Orphenadrine Extended-Release Tablets-Inova 4/1 topical
- Orphenadrine Extended-Release Tablets-Inova 8/2 topical
- Orphenadrine Extended-Release Tablets-Inova ACT